Oyster Point Pharma Inc (Oyster Point), a subsidiary of Viatris Inc, is a clinical-stage biopharmaceutical company provides facilities on the discovery, development and commercialization of novel therapeutics to treat ophthalmic diseases. The company's lead product candidate OC-01 (varenicline solution), a nicotinic acetylcholine receptors (nAChR) that used to develop as a preservative-free nasal spray to treat the indications and symptoms of dry eye disease (DED).. It is also investigating OC-02 (simpinicline) nasal sprays, in Phase 2b clinical studies for the treatment of DED. Oyster Point is headquartered in Princeton, New Jersey, the US.
Headquarters
United States of America
Address
202 Carnegie Center, Suite 106, Princeton, New Jersey, 08540
Website
www.oysterpointrx.com
Telephone
1 609 3829032
Industry
Pharmaceuticals and Healthcare
Revenue (2021)
$24.5M
Products and Services
| Products |
|---|
| Pipeline Products |
| OC-01 ( Varenicline Solution) |
| Ocular Surface Disease |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Oyster Point Pharma Inc | Ocular Therapeutix Inc | CalciMedica Inc | KALA BIO Inc | Kiora Pharmaceuticals Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Princeton | Bedford | La Jolla | Arlington | Encinitas |
| State/Province | New Jersey | Massachusetts | California | Massachusetts | California |
| No. of Employees | - | 267 | 8 | 43 | 12 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Marian Macsai | Chief Medical Officer | Senior Management | - | - |
| Donald Santel | Chairman | Non Executive Board | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer